Contrasting Global and Patient-Specific Regression Models via a Neural Network Representation

Summary

This paper introduces a diagnostic tool to assess the adequacy of global clinical prediction models by identifying patient subgroups for whom personalized, localized regression models are more appropriate. It addresses the challenge of high-dimensional data by leveraging an autoencoder to learn a latent representation, facilitating robust localized regression. The tool ultimately aims to characterize patients whose outcome associations deviate from a global model, providing insight into specific clinical needs.

Medical Relevance

This tool offers clinicians and researchers a method to discern when and for whom a general prediction model might be insufficient, enabling the development of more accurate, personalized treatment and risk stratification strategies for specific patient subgroups in medical practice.

AI Health Application

The research applies neural networks (specifically autoencoders) for dimension reduction to create a latent representation of patient data. This AI-driven dimension reduction is then used to facilitate robust localized regression, enabling the identification and characterization of patient subgroups for whom global clinical prediction models are inadequate. This directly supports the development of more accurate, personalized clinical prediction models and diagnostic tools in healthcare.

Key Points

• Proposes a diagnostic tool to contrast global and patient-specific (local) regression models in clinical prediction.
• Identifies specific regions in the predictor space where a global model may be inadequate for patient representation.
• Employs a localized regression approach to detect deviations from the global model's assumptions for certain subgroups.
• Addresses high-dimensional predictors by using an autoencoder for dimension reduction, creating a latent space optimized for both data reconstruction and revealing local outcome associations.
• Demonstrates the utility of the approach in a clinical study involving patients with chronic obstructive pulmonary disease (COPD).
• Findings indicate that while global models suffice for most, specific subgroups indeed benefit from personalized models.
• Allows mapping personalized subgroup models back to original predictors, providing actionable insights into why global models fall short for these groups and characterizing the deviating subgroups.

Clinical Impact

This tool can significantly improve the precision of clinical prediction models by identifying patients who would benefit most from personalized care pathways. It can guide the development of targeted interventions, refine risk stratification, and ultimately lead to more effective and patient-specific medical decisions by highlighting the underlying reasons for deviations from global models.

Limitations

Not explicitly mentioned in the abstract.

Future Directions

Not explicitly mentioned in the abstract.

Medical Domains

Keywords

Abstract

When developing clinical prediction models, it can be challenging to balance between global models that are valid for all patients and personalized models tailored to individuals or potentially unknown subgroups. To aid such decisions, we propose a diagnostic tool for contrasting global regression models and patient-specific (local) regression models. The core utility of this tool is to identify where and for whom a global model may be inadequate. We focus on regression models and specifically suggest a localized regression approach that identifies regions in the predictor space where patients are not well represented by the global model. As localization becomes challenging when dealing with many predictors, we propose modeling in a dimension-reduced latent representation obtained from an autoencoder. Using such a neural network architecture for dimension reduction enables learning a latent representation simultaneously optimized for both good data reconstruction and for revealing local outcome-related associations suitable for robust localized regression. We illustrate the proposed approach with a clinical study involving patients with chronic obstructive pulmonary disease. Our findings indicate that the global model is adequate for most patients but that indeed specific subgroups benefit from personalized models. We also demonstrate how to map these subgroup models back to the original predictors, providing insight into why the global model falls short for these groups. Thus, the principal application and diagnostic yield of our tool is the identification and characterization of patients or subgroups whose outcome associations deviate from the global model.